SARS-CoV-2 has accumulated many mutations since its emergence in late 2019. Nucleotide substitutions leading to amino acid replacements constitute the primary material for natural selection. Insertions, deletions, and substitutions appear to be critical for coronavirus's macro- and microevolution. Understanding the molecular mechanisms of mutations in the mutational hotspots (positions, loci with recurrent mutations, and nucleotide context) is important for disentangling roles of mutagenesis and selection. In the SARS-CoV-2 genome, deletions and insertions are frequently associated with repetitive sequences, whereas C>U substitutions are often surrounded by nucleotides resembling the APOBEC mutable motifs. We describe various approaches to mutation spectra analyses, including the context features of RNAs that are likely to be involved in the generation of recurrent mutations. We also discuss the interplay between mutations and natural selection as a complex evolutionary trend. The substantial variability and complexity of pipelines for the reconstruction of mutations and the huge number of genomic sequences are major problems for the analyses of mutations in the SARS-CoV-2 genome. As a solution, we advocate for the development of a centralized database of predicted mutations, which needs to be updated on a regular basis.

Center for Collaborative Research in Health Disparities RCMI Program Medical Sciences Campus University of Puerto Rico San Juan 00936 Puerto Rico

Eppley Institute for Research in Cancer and Allied Diseases University of Nebraska Medical Center Omaha NE 68198 USA

Life Science Research Centre Faculty of Science University of Ostrava 710 00 Ostrava Czech Republic

National Eye Institute National Institutes of Health Bethesda MD 20892 USA

Zobrazit více v PubMed

Drake J.W., Baltz R.H. The biochemistry of mutagenesis. Annu. Rev. Biochem. 1976;45:11–37. doi: 10.1146/annurev.bi.45.070176.000303. PubMed DOI

Maki H. Origins of spontaneous mutations: Specificity and directionality of base-substitution, frameshift, and sequence-substitution mutageneses. Annu. Rev. Genet. 2002;36:279–303. doi: 10.1146/annurev.genet.36.042602.094806. PubMed DOI

Rogozin I.B., Pavlov Y.I. Theoretical analysis of mutation hotspots and their DNA sequence context specificity. Mutat. Res. 2003;544:65–85. doi: 10.1016/S1383-5742(03)00032-2. PubMed DOI

Drake J.W., Charlesworth B., Charlesworth D., Crow J.F. Rates of spontaneous mutation. Genetics. 1998;148:1667–1686. doi: 10.1093/genetics/148.4.1667. PubMed DOI PMC

Rogozin I.B., Pavlov Y.I., Goncearenco A., De S., Lada A.G., Poliakov E., Panchenko A.R., Cooper D.N. Mutational signatures and mutable motifs in cancer genomes. Brief. Bioinform. 2018;19:1085–1101. doi: 10.1093/bib/bbx049. PubMed DOI PMC

van Dorp L., Richard D., Tan C.C.S., Shaw L.P., Acman M., Balloux F. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat. Commun. 2020;11:5986. doi: 10.1038/s41467-020-19818-2. PubMed DOI PMC

Bloom J.D., Beichman A.C., Neher R.A., Harris K. Evolution of the SARS-CoV-2 mutational spectrum. Mol. Biol. Evol. 2023;40:msad085. doi: 10.1093/molbev/msad085. PubMed DOI PMC

Saldivar-Espinoza B., Macip G., Garcia-Segura P., Mestres-Truyol J., Puigbo P., Cereto-Massague A., Pujadas G., Garcia-Vallve S. Prediction of recurrent mutations in SARS-CoV-2 using artificial neural networks. Int. J. Mol. Sci. 2022;23:14683. doi: 10.3390/ijms232314683. PubMed DOI PMC

Rochman N.D., Wolf Y.I., Faure G., Mutz P., Zhang F., Koonin E.V. Ongoing global and regional adaptive evolution of SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2021;118:e2104241118. doi: 10.1073/pnas.2104241118. PubMed DOI PMC

Chang M.T., Asthana S., Gao S.P., Lee B.H., Chapman J.S., Kandoth C., Gao J., Socci N.D., Solit D.B., Olshen A.B., et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat. Biotechnol. 2016;34:155–163. doi: 10.1038/nbt.3391. PubMed DOI PMC

McCarthy K.R., Rennick L.J., Nambulli S., Robinson-McCarthy L.R., Bain W.G., Haidar G., Duprex W.P. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science. 2021;371:1139–1142. doi: 10.1126/science.abf6950. PubMed DOI PMC

McCullers J.A., Wang G.C., He S., Webster R.G. Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature. J. Virol. 1999;73:7343–7348. doi: 10.1128/JVI.73.9.7343-7348.1999. PubMed DOI PMC

Taylor K.Y., Agu I., Jose I., Mantynen S., Campbell A.J., Mattson C., Chou T.W., Zhou B., Gresham D., Ghedin E., et al. Influenza A virus reassortment is strain dependent. PLoS Pathog. 2023;19:e1011155. doi: 10.1371/journal.ppat.1011155. PubMed DOI PMC

Zdravkovic M., Berger-Estilita J., Zdravkovic B., Berger D. Scientific quality of COVID-19 and SARS-CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study. PLoS ONE. 2020;15:e0241826. doi: 10.1371/journal.pone.0241826. PubMed DOI PMC

Zhang Y.Z., Holmes E.C. A genomic perspective on the origin and emergence of SARS-CoV-2. Cell. 2020;181:223–227. doi: 10.1016/j.cell.2020.03.035. PubMed DOI PMC

Forni D., Cagliani R., Clerici M., Sironi M. Molecular evolution of human coronavirus genomes. Trends Microbiol. 2017;25:35–48. doi: 10.1016/j.tim.2016.09.001. PubMed DOI PMC

Narayanan K., Huang C., Makino S. SARS coronavirus accessory proteins. Virus Res. 2008;133:113–121. doi: 10.1016/j.virusres.2007.10.009. PubMed DOI PMC

Li J.Y., Liao C.H., Wang Q., Tan Y.J., Luo R., Qiu Y., Ge X.Y. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway. Virus Res. 2020;286:198074. doi: 10.1016/j.virusres.2020.198074. PubMed DOI PMC

Stadler K., Masignani V., Eickmann M., Becker S., Abrignani S., Klenk H.D., Rappuoli R. SARS—beginning to understand a new virus. Nat. Rev. Microbiol. 2003;1:209–218. doi: 10.1038/nrmicro775. PubMed DOI PMC

Finkel Y., Mizrahi O., Nachshon A., Weingarten-Gabbay S., Morgenstern D., Yahalom-Ronen Y., Tamir H., Achdout H., Stein D., Israeli O., et al. The coding capacity of SARS-CoV-2. Nature. 2021;589:125–130. doi: 10.1038/s41586-020-2739-1. PubMed DOI

Pancer K., Milewska A., Owczarek K., Dabrowska A., Kowalski M., Labaj P.P., Branicki W., Sanak M., Pyrc K. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans. PLoS Pathog. 2020;16:e1008959. doi: 10.1371/journal.ppat.1008959. PubMed DOI PMC

Mack A.H., Menzies G., Southgate A., Jones D.D., Connor T.R. A proofreading mutation with an allosteric effect allows a cluster of SARS-CoV-2 viruses to rapidly evolve. Mol. Biol. Evol. 2023;40:msad209. doi: 10.1093/molbev/msad209. PubMed DOI PMC

Smith E.C., Blanc H., Surdel M.C., Vignuzzi M., Denison M.R. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: Evidence for proofreading and potential therapeutics. PLoS Pathog. 2013;9:e1003565. doi: 10.1371/journal.ppat.1003565. PubMed DOI PMC

Long S. SARS-CoV-2 subgenomic RNAs: Characterization, utility, and perspectives. Viruses. 2021;13:1923. doi: 10.3390/v13101923. PubMed DOI PMC

Tang M.E., Ng K.L., Edslev S.M., Ellegaard K., Danish C.-G.C., Stegger M., Alexandersen S. Comparative subgenomic mRNA profiles of SARS-CoV-2 Alpha, Delta and Omicron BA.1, BA.2 and BA.5 sub-lineages using Danish COVID-19 genomic surveillance data. EBioMedicine. 2023;93:104669. doi: 10.1016/j.ebiom.2023.104669. PubMed DOI PMC

Chen Z., Ng R.W.Y., Lui G., Ling L., Chow C., Yeung A.C.M., Boon S.S., Wang M.H., Chan K.C.C., Chan R.W.Y., et al. Profiling of SARS-CoV-2 subgenomic rnas in clinical specimens. Microbiol. Spectr. 2022;10:e0018222. doi: 10.1128/spectrum.00182-22. PubMed DOI PMC

Hadfield J., Megill C., Bell S.M., Huddleston J., Potter B., Callender C., Sagulenko P., Bedford T., Neher R.A. Nextstrain: Real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121–4123. doi: 10.1093/bioinformatics/bty407. PubMed DOI PMC

Garushyants S.K., Rogozin I.B., Koonin E.V. Template switching and duplications in SARS-CoV-2 genomes give rise to insertion variants that merit monitoring. Commun. Biol. 2021;4:1343. doi: 10.1038/s42003-021-02858-9. PubMed DOI PMC

Klimczak L.J., Randall T.A., Saini N., Li J.L., Gordenin D.A. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic. PLoS ONE. 2020;15:e0237689. doi: 10.1371/journal.pone.0237689. PubMed DOI PMC

Rogozin I.B., Saura A., Bykova A., Brover V., Yurchenko V. Deletions across the SARS-CoV-2 genome: Molecular mechanisms and putative functional consequences of deletions in accessory genes. Microorganisms. 2023;11:229. doi: 10.3390/microorganisms11010229. PubMed DOI PMC

Bykova A., Saura A., Glazko G.V., Roche-Lima A., Yurchenko V., Rogozin I.B. The 29-nucleotide deletion in SARS-CoV: Truncated versions of ORF8 are under purifying selection. BMC Genomics. 2023;24:387. doi: 10.1186/s12864-023-09482-3. PubMed DOI PMC

Mavian C., Pond S.K., Marini S., Magalis B.R., Vandamme A.M., Dellicour S., Scarpino S.V., Houldcroft C., Villabona-Arenas J., Paisie T.K., et al. Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-CoV-2 infections unreliable. Proc. Natl. Acad. Sci. USA. 2020;117:12522–12523. doi: 10.1073/pnas.2007295117. PubMed DOI PMC

Turakhia Y., De Maio N., Thornlow B., Gozashti L., Lanfear R., Walker C.R., Hinrichs A.S., Fernandes J.D., Borges R., Slodkowicz G., et al. Stability of SARS-CoV-2 phylogenies. PLoS Genet. 2020;16:e1009175. doi: 10.1371/journal.pgen.1009175. PubMed DOI PMC

Turakhia Y., Thornlow B., Hinrichs A.S., De Maio N., Gozashti L., Lanfear R., Haussler D., Corbett-Detig R. Ultrafast Sample placement on Existing tRees (UShER) enables real-time phylogenetics for the SARS-CoV-2 pandemic. Nat. Genet. 2021;53:809–816. doi: 10.1038/s41588-021-00862-7. PubMed DOI PMC

McBroome J., Thornlow B., Hinrichs A.S., Kramer A., De Maio N., Goldman N., Haussler D., Corbett-Detig R., Turakhia Y. A daily-updated database and tools for comprehensive SARS-CoV-2 mutation-annotated trees. Mol. Biol. Evol. 2021;38:5819–5824. doi: 10.1093/molbev/msab264. PubMed DOI PMC

Saldivar-Espinoza B., Garcia-Segura P., Novau-Ferre N., Macip G., Martinez R., Puigbo P., Cereto-Massague A., Pujadas G., Garcia-Vallve S. The mutational landscape of SARS-CoV-2. Int. J. Mol. Sci. 2023;24:9072. doi: 10.3390/ijms24109072. PubMed DOI PMC

Flower T.G., Buffalo C.Z., Hooy R.M., Allaire M., Ren X., Hurley J.H. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc. Natl. Acad. Sci. USA. 2021;118:e2021785118. doi: 10.1073/pnas.2021785118. PubMed DOI PMC

Magazine N., Zhang T., Wu Y., McGee M.C., Veggiani G., Huang W. Mutations and evolution of the SARS-CoV-2 Spike protein. Viruses. 2022;14:640. doi: 10.3390/v14030640. PubMed DOI PMC

Scarpa F., Azzena I., Ciccozzi A., Giovanetti M., Locci C., Casu M., Fiori P.L., Borsetti A., Cella E., Quaranta M., et al. Integrative genome-based survey of the SARS-CoV-2 Omicron XBB.1.16 variant. Int. J. Mol. Sci. 2023;24:13573. doi: 10.3390/ijms241713573. PubMed DOI PMC

Zhu X., Mannar D., Srivastava S.S., Berezuk A.M., Demers J.P., Saville J.W., Leopold K., Li W., Dimitrov D.S., Tuttle K.S., et al. Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. PLoS Biol. 2021;19:e3001237. doi: 10.1371/journal.pbio.3001237. PubMed DOI PMC

Mannar D., Saville J.W., Zhu X., Srivastava S.S., Berezuk A.M., Tuttle K.S., Marquez A.C., Sekirov I., Subramaniam S. SARS-CoV-2 omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex. Science. 2022;375:760–764. doi: 10.1126/science.abn7760. PubMed DOI PMC

Kimura M. Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature. 1977;267:275–276. doi: 10.1038/267275a0. PubMed DOI

Yang Z., Bielawski J.P. Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 2000;15:496–503. doi: 10.1016/S0169-5347(00)01994-7. PubMed DOI PMC

Koonin E.V., Rogozin I.B. Getting positive about selection. Genome Biol. 2003;4:331. doi: 10.1186/gb-2003-4-8-331. PubMed DOI PMC

Bukur T., Riesgo-Ferreiro P., Sorn P., Gudimella R., Hausmann J., Rosler T., Lower M., Schrors B., Sahin U. CoVigator-a knowledge base for navigating SARS-CoV-2 genomic variants. Viruses. 2023;15:1391. doi: 10.3390/v15061391. PubMed DOI PMC

Peacock T.P., Penrice-Randal R., Hiscox J.A., Barclay W.S. SARS-CoV-2 one year on: Evidence for ongoing viral adaptation. J. Gen. Virol. 2021;102:001584. doi: 10.1099/jgv.0.001584. PubMed DOI PMC

Panzera Y., Calleros L., Goni N., Marandino A., Techera C., Grecco S., Ramos N., Frabasile S., Tomas G., Condon E., et al. Consecutive deletions in a unique Uruguayan SARS-CoV-2 lineage evidence the genetic variability potential of accessory genes. PLoS ONE. 2022;17:e0263563. doi: 10.1371/journal.pone.0263563. PubMed DOI PMC

Young B.E., Fong S.W., Chan Y.H., Mak T.M., Ang L.W., Anderson D.E., Lee C.Y., Amrun S.N., Lee B., Goh Y.S., et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: An observational cohort study. Lancet. 2020;396:603–611. doi: 10.1016/S0140-6736(20)31757-8. PubMed DOI PMC

Rogozin I.B., Charyyeva A., Sidorenko I.A., Babenko V.N., Yurchenko V. Frequent recombination events in Leishmania donovani: Mining population data. Pathogens. 2020;9:572. doi: 10.3390/pathogens9070572. PubMed DOI PMC

Lovett S.T., Gluckman T.J., Simon P.J., Sutera V.A., Jr., Drapkin P.T. Recombination between repeats in Escherichia coli by a recA-independent, proximity-sensitive mechanism. Mol. Gen. Genet. 1994;245:294–300. doi: 10.1007/BF00290109. PubMed DOI

Lovett S.T. Encoded errors: Mutations and rearrangements mediated by misalignment at repetitive DNA sequences. Mol. Microbiol. 2004;52:1243–1253. doi: 10.1111/j.1365-2958.2004.04076.x. PubMed DOI

Bzymek M., Saveson C.J., Feschenko V.V., Lovett S.T. Slipped misalignment mechanisms of deletion formation: In vivo susceptibility to nucleases. J. Bacteriol. 1999;181:477–482. doi: 10.1128/JB.181.2.477-482.1999. PubMed DOI PMC

Hu X., Worton R.G. Partial gene duplication as a cause of human disease. Hum. Mutat. 1992;1:3–12. doi: 10.1002/humu.1380010103. PubMed DOI

Shen L., Bard J.D., Triche T.J., Judkins A.R., Biegel J.A., Gai X. Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations. Emerg. Microbes Infect. 2021;10:1293–1299. doi: 10.1080/22221751.2021.1943540. PubMed DOI PMC

Akaishi T., Fujiwara K., Ishii T. Insertion/deletion hotspots in the Nsp2, Nsp3, S1, and ORF8 genes of SARS-related coronaviruses. BMC Ecol. Evol. 2022;22:123. doi: 10.1186/s12862-022-02078-7. PubMed DOI PMC

Sinden R.R., Zheng G.X., Brankamp R.G., Allen K.N. On the deletion of inverted repeated DNA in Escherichia coli: Effects of length, thermal stability, and cruciform formation in vivo. Genetics. 1991;129:991–1005. doi: 10.1093/genetics/129.4.991. PubMed DOI PMC

Gordenin D.A., Resnick M.A. Yeast ARMs (DNA at-risk motifs) can reveal sources of genome instability. Mutat. Res. 1998;400:45–58. doi: 10.1016/S0027-5107(98)00047-5. PubMed DOI

Wakeley J. The excess of transitions among nucleotide substitutions: New methods of estimating transition bias underscore its significance. Trends Ecol. Evol. 1996;11:158–162. doi: 10.1016/0169-5347(96)10009-4. PubMed DOI

Vogel F., Rohrborn G. Amino-acid substitutions in haemoglobins and the mutation process. Nature. 1966;210:116–117. doi: 10.1038/210116a0. PubMed DOI

Fitch W.M. Evidence suggesting a non-random character to nucleotide replacements in naturally occurring mutations. J. Mol. Biol. 1967;26:499–507. doi: 10.1016/0022-2836(67)90317-8. PubMed DOI

Gojobori T., Li W.H., Graur D. Patterns of nucleotide substitution in pseudogenes and functional genes. J. Mol. Evol. 1982;18:360–369. doi: 10.1007/BF01733904. PubMed DOI

Li W.H., Wu C.I., Luo C.C. Nonrandomness of point mutation as reflected in nucleotide substitutions in pseudogenes and its evolutionary implications. J. Mol. Evol. 1984;21:58–71. doi: 10.1007/BF02100628. PubMed DOI

Sankoff D., Morel C., Cedergren R.J. Evolution of 5S RNA and the non-randomness of base replacement. Nat. New Biol. 1973;245:232–234. doi: 10.1038/newbio245232a0. PubMed DOI

Hixson J.E., Brown W.M. A comparison of the small ribosomal RNA genes from the mitochondrial DNA of the great apes and humans: Sequence, structure, evolution, and phylogenetic implications. Mol. Biol. Evol. 1986;3:1–18. doi: 10.1093/oxfordjournals.molbev.a040379. PubMed DOI

Simmonds P., Ansari M.A. Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA. PLoS Pathog. 2021;17:e1009596. doi: 10.1371/journal.ppat.1009596. PubMed DOI PMC

Nakata Y., Ode H., Kubota M., Kasahara T., Matsuoka K., Sugimoto A., Imahashi M., Yokomaku Y., Iwatani Y. Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic Acids Res. 2023;51:783–795. doi: 10.1093/nar/gkac1238. PubMed DOI PMC

Pecori R., Di Giorgio S., Paulo Lorenzo J., Nina Papavasiliou F. Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination. Nat. Rev. Genet. 2022;23:505–518. doi: 10.1038/s41576-022-00459-8. PubMed DOI PMC

Ooms M., Krikoni A., Kress A.K., Simon V., Munk C. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1. J. Virol. 2012;86:6097–6108. doi: 10.1128/JVI.06570-11. PubMed DOI PMC

Harris R.S., Dudley J.P. APOBECs and virus restriction. Virology. 2015;479–480:131–145. doi: 10.1016/j.virol.2015.03.012. PubMed DOI PMC

Kim K., Calabrese P., Wang S., Qin C., Rao Y., Feng P., Chen X.S. The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness. Sci. Rep. 2022;12:14972. doi: 10.1038/s41598-022-19067-x. PubMed DOI PMC

Song Y., He X., Yang W., Wu Y., Cui J., Tang T., Zhang R. Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution. Nucleic Acids Res. 2022;50:2509–2521. doi: 10.1093/nar/gkac120. PubMed DOI PMC

Panchin A.Y., Panchin Y.V. Excessive G-U transversions in novel allele variants in SARS-CoV-2 genomes. PeerJ. 2020;8:e9648. doi: 10.7717/peerj.9648. PubMed DOI PMC

Shcherbakova P.V., Pavlov Y.I., Chilkova O., Rogozin I.B., Johansson E., Kunkel T.A. Unique error signature of the four-subunit yeast DNA polymerase epsilon. J. Biol. Chem. 2003;278:43770–43780. doi: 10.1074/jbc.M306893200. PubMed DOI

Cecchini R., Cecchini A.L. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med. Hypotheses. 2020;143:110102. doi: 10.1016/j.mehy.2020.110102. PubMed DOI PMC

Suhail S., Zajac J., Fossum C., Lowater H., McCracken C., Severson N., Laatsch B., Narkiewicz-Jodko A., Johnson B., Liebau J., et al. Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: A review. Protein J. 2020;39:644–656. doi: 10.1007/s10930-020-09935-8. PubMed DOI PMC

Boo S.H., Kim Y.K. The emerging role of RNA modifications in the regulation of mRNA stability. Exp. Mol. Med. 2020;52:400–408. doi: 10.1038/s12276-020-0407-z. PubMed DOI PMC

Frost S.D.W., Magalis B.R., Kosakovsky Pond S.L. Neutral theory and rapidly evolving viral pathogens. Mol. Biol. Evol. 2018;35:1348–1354. doi: 10.1093/molbev/msy088. PubMed DOI PMC

Jackson A.P., Berry A., Aslett M., Allison H.C., Burton P., Vavrova-Anderson J., Brown R., Browne H., Corton N., Hauser H., et al. Antigenic diversity is generated by distinct evolutionary mechanisms in African trypanosome species. Proc. Natl. Acad. Sci. USA. 2012;109:3416–3421. doi: 10.1073/pnas.1117313109. PubMed DOI PMC

Bangs J.D. Evolution of antigenic variation in african trypanosomes: Variant surface glycoprotein expression, structure, and function. Bioessays. 2018;40:e1800181. doi: 10.1002/bies.201800181. PubMed DOI PMC

Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence. J. Clin. Invest. 2009;119:1745–1754. doi: 10.1172/JCI39133. PubMed DOI PMC

Frost S.D., Wrin T., Smith D.M., Kosakovsky Pond S.L., Liu Y., Paxinos E., Chappey C., Galovich J., Beauchaine J., Petropoulos C.J., et al. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. USA. 2005;102:18514–18519. doi: 10.1073/pnas.0504658102. PubMed DOI PMC

Woelk C.H., Holmes E.C. Reduced positive selection in vector-borne RNA viruses. Mol. Biol. Evol. 2002;19:2333–2336. doi: 10.1093/oxfordjournals.molbev.a004059. PubMed DOI

Henn M.R., Boutwell C.L., Charlebois P., Lennon N.J., Power K.A., Macalalad A.R., Berlin A.M., Malboeuf C.M., Ryan E.M., Gnerre S., et al. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog. 2012;8:e1002529. doi: 10.1371/journal.ppat.1002529. PubMed DOI PMC

du Plessis L., McCrone J.T., Zarebski A.E., Hill V., Ruis C., Gutierrez B., Raghwani J., Ashworth J., Colquhoun R., Connor T.R., et al. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science. 2021;371:708–712. doi: 10.1126/science.abf2946. PubMed DOI PMC

Kemp S.A., Collier D.A., Datir R.P., Ferreira I., Gayed S., Jahun A., Hosmillo M., Rees-Spear C., Mlcochova P., Lumb I.U., et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592:277–282. doi: 10.1038/s41586-021-03291-y. PubMed DOI PMC

Sepulcri C., Dentone C., Mikulska M., Bruzzone B., Lai A., Fenoglio D., Bozzano F., Bergna A., Parodi A., Altosole T., et al. The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient—A case study. Open Forum Infect. Dis. 2021;8:ofab217. doi: 10.1093/ofid/ofab217. PubMed DOI PMC

Cerutti G., Guo Y., Zhou T., Gorman J., Lee M., Rapp M., Reddem E.R., Yu J., Bahna F., Bimela J., et al. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe. 2021;29:819–833. doi: 10.1016/j.chom.2021.03.005. PubMed DOI PMC

Cagliani R., Forni D., Clerici M., Sironi M. Computational inference of selection underlying the evolution of the novel coronavirus, severe acute respiratory syndrome coronavirus 2. J. Virol. 2020;94:e00411–e00420. doi: 10.1128/JVI.00411-20. PubMed DOI PMC

Li W., Zhang C., Sui J., Kuhn J.H., Moore M.J., Luo S., Wong S.K., Huang I.C., Xu K., Vasilieva N., et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005;24:1634–1643. doi: 10.1038/sj.emboj.7600640. PubMed DOI PMC

Sawyer S.L., Emerman M., Malik H.S. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2004;2:E275. doi: 10.1371/journal.pbio.0020275. PubMed DOI PMC

Maisnier-Patin S., Andersson D.I. Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res. Microbiol. 2004;155:360–369. doi: 10.1016/j.resmic.2004.01.019. PubMed DOI

Breen M.S., Kemena C., Vlasov P.K., Notredame C., Kondrashov F.A. Epistasis as the primary factor in molecular evolution. Nature. 2012;490:535–538. doi: 10.1038/nature11510. PubMed DOI

Kannan S., Shaik Syed Ali P., Sheeza A. Omicron (B.1.1.529)—Variant of concern—Molecular profile and epidemiology: A mini review. Eur. Rev. Med. Pharmacol. Sci. 2021;25:8019–8022. doi: 10.26355/eurrev_202112_27653. PubMed DOI

Muth D., Corman V.M., Roth H., Binger T., Dijkman R., Gottula L.T., Gloza-Rausch F., Balboni A., Battilani M., Rihtaric D., et al. Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission. Sci. Rep. 2018;8:15177. doi: 10.1038/s41598-018-33487-8. PubMed DOI PMC

Andersen K.G., Rambaut A., Lipkin W.I., Holmes E.C., Garry R.F. The proximal origin of SARS-CoV-2. Nat. Med. 2020;26:450–452. doi: 10.1038/s41591-020-0820-9. PubMed DOI PMC

Rasmussen A.L. On the origins of SARS-CoV-2. Nat. Med. 2021;27:9. doi: 10.1038/s41591-020-01205-5. PubMed DOI

Cyranoski D. Profile of a killer: The complex biology powering the coronavirus pandemic. Nature. 2020;581:22–26. doi: 10.1038/d41586-020-01315-7. PubMed DOI

Postnikova O.A., Uppal S., Huang W., Kane M.A., Villasmil R., Rogozin I.B., Poliakov E., Redmond T.M. The functional consequences of the novel ribosomal pausing site in SARS-CoV-2 spike glycoprotein RNA. Int. J. Mol. Sci. 2021;22:6490. doi: 10.3390/ijms22126490. PubMed DOI PMC

Li J., Jia H., Tian M., Wu N., Yang X., Qi J., Ren W., Li F., Bian H. SARS-CoV-2 and emerging variants: Unmasking structure, function, infection, and immune escape mechanisms. Front. Cell Infect. Microbiol. 2022;12:869832. doi: 10.3389/fcimb.2022.869832. PubMed DOI PMC

Plante J.A., Mitchell B.M., Plante K.S., Debbink K., Weaver S.C., Menachery V.D. The variant gambit: COVID-19’s next move. Cell Host Microbe. 2021;29:508–515. doi: 10.1016/j.chom.2021.02.020. PubMed DOI PMC

Davidson A.D., Williamson M.K., Lewis S., Shoemark D., Carroll M.W., Heesom K.J., Zambon M., Ellis J., Lewis P.A., Hiscox J.A., et al. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein. Genome Med. 2020;12:68. doi: 10.1186/s13073-020-00763-0. PubMed DOI PMC

Di Giorgio S., Martignano F., Torcia M.G., Mattiuz G., Conticello S.G. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2. Sci. Adv. 2020;6:eabb5813. doi: 10.1126/sciadv.abb5813. PubMed DOI PMC

Simas M.C.C., Costa S.M., Gomes P., Cruz N., Correa I.A., de Souza M.R.M., Dornelas-Ribeiro M., Nogueira T.L.S., Santos C., Hoffmann L., et al. Evaluation of SARS-CoV-2 ORF7a deletions from COVID-19-positive individuals and its impact on virus spread in cell culture. Viruses. 2023;15:801. doi: 10.3390/v15030801. PubMed DOI PMC

Aroldi A., Angaroni F., D’Aliberti D., Spinelli S., Crespiatico I., Crippa V., Piazza R., Graudenzi A., Ramazzotti D. Characterization of SARS-CoV-2 mutational signatures from 1.5+ million raw sequencing samples. Viruses. 2022;15:7. doi: 10.3390/v15010007. PubMed DOI PMC

Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280. doi: 10.1016/j.cell.2020.02.052. PubMed DOI PMC

Eriksen A.Z., Moller R., Makovoz B., Uhl S.A., tenOever B.R., Blenkinsop T.A. SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium. Cell Stem Cell. 2021;28:1205–1220. doi: 10.1016/j.stem.2021.04.028. PubMed DOI PMC

Uppal S., Postnikova O., Villasmil R., Rogozin I.B., Bocharov A.V., Eggerman T.L., Poliakov E., Redmond T.M. Low-Density Lipoprotein Receptor (LDLR) is involved in internalization of lentiviral particles pseudotyped with SARS-CoV-2 spike protein in ocular cells. Int. J. Mol. Sci. 2023;24:11860. doi: 10.3390/ijms241411860. PubMed DOI PMC

Widagdo W., Sooksawasdi Na Ayudhya S., Hundie G.B., Haagmans B.L. Host determinants of MERS-CoV transmission and pathogenesis. Viruses. 2019;11:280. doi: 10.3390/v11030280. PubMed DOI PMC

Cui S., Liu Y., Zhao J., Peng X., Lu G., Shi W., Pan Y., Zhang D., Yang P., Wang Q. An updated review on SARS-CoV-2 infection in animals. Viruses. 2022;14:1527. doi: 10.3390/v14071527. PubMed DOI PMC